Cell mechanical phenotype, or 'mechanotype', determines how physical stresses are transduced into the cell, and can also signal a transformation in a cell's physiological state, such as in malignant transformation. However, the molecules that regulate cell mechanotype, and the functional consequences in disease progression remain poorly understood. If we could obtain higher throughput measurements of cell mechanotype, this would enable a deeper understanding of the molecular origins of cell mechanotype, as well as screening based on mechanotype. To address these needs, we invented a higher throughput mechanotyping platform that is based on microfluidic and microfiltration technologies. I will discuss how we are applying our mechanotyping methods to screen panels of ovarian, breast, and pancreatic cancer cells. One specific example application is our discovery that stress hormones, which promote metastasis in mice, also elicit changes in cell mechanical properties: we find that breast cancer cells treated with isoproterenol become stiffer due to actin remodeling, myosin II activity, and increased calcium. Using assays to measure cell invasion through in vitro protein networks, we found that these stiffer isoproterenol-treated breast cancer cells are more invasive. Taken together, our results provide fundamental insight into how the mechanical phenotype of cancer cells is associated with their functional behavior.
